Moderna
MRNA
#1337
Rank
NZ$27.88 B
Marketcap
NZ$71.35
Share price
1.35%
Change (1 day)
9.85%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -NZ$5.46 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$2.20 Billion. In 2024 the company made an earning of -NZ$5.98 Billion, an increase over its 2023 earnings that were of -NZ$6.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$5.46 Billion-8.81%
2024 -NZ$5.98 Billion-8.22%
2023 -NZ$6.52 Billion-140.65%
2022 NZ$16.02 B-27.81%
2021 NZ$22.19 B-1911.15%
2020 -NZ$1.23 Billion44.7%
2019 -NZ$0.85 Billion28.63%
2018 -NZ$0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.04 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.39 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$38.52 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$79.13 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$69.68 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.21 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$0.23 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA